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Abstract
Background: Autotransporters are attractive cell surface display vehicles as they lack complex adaptor proteins
necessary for protein export. Recent reports have suggested that the native effector domain (a domain) and
translocation domain (b domain) interact with each other to drive translocation of the effector domain to the
outer membrane. In this report we compared the expression, surface localisation and folding of TEM-1 b-lactamase
(Bla) and maltose binding protein (MalE or MBP) fused to either full length Shigella flexneri IcsA (IcsA)
autotransporter or to the b domain alone (IcsAb) to determine the contribution of the native IcsA a domain in
presenting the fusion proteins on the surface of E. coli K-12 UT5600 (ΔompT).
Results: Expression of IcsA-Bla was greater than IcsAb-Bla. High levels of IcsA-MalE were detected but IcsAb-MalE
was not expressed. All fusion proteins other than IcsAb-MalE were localised to the outer membrane and were
detected on the surface of UT5600 via immunofluorescence microscopy. All bacteria expressing IcsA-MalE were
labelled with both a-IcsA and a-MBP. UT5600 expressing IcsAb-MalE was not labelled with a-MBP. A third of
UT5600 expressing IcsA-Bla were detectable with a-Bla but only 5% of UT5600 (IcsAb-Bla) were labelled with a-Bla.
The correct folding of the Bla moiety when fused to IcsA and IcsAb was also retained as UT5600 expressing either
fusion protein exhibited a decreased zone of inhibition in the presence of ampicillin. UT5600 expressing IcsA-Bla
was more resistant compared to UT5600 expressing IcsAb-Bla.
Conclusions: The export mechanism of autotransporters is not well understood but accumulating evidence
suggest a critical role for the native effector or a domain in facilitating its own export via interactions with the
translocation or b domain. This is the first report directly comparing expression of heterologous proteins fused to
the full length IcsA autotransporter and fusion to the b domain alone. Protein expression and surface presentation
of the fusion proteins were dramatically improved when fused to IcsA rather than IcsAb. Future studies involved in
designing autotransporters as cell surface display vehicles would benefit from including the native a domain. This
work also provides further evidence for a key interaction between the autotransporter a and b domains.
Background
Expression of heterologous proteins and peptides on bac-
terial surface are important for a wide range of applica-
tions such as vaccine production, bioremediation,
biocatalysis, peptide library screening and translocation
studies [1]. The autotransporter or type Va secretary
pathway is an attractive cell surface display vehicle due to
the lack of complex adaptor machineries necessary for
protein export compared to other Gram negative export
pathways [2]. High expression of recombinant molecules
(> 10
5) per cell without adverse effects on cell viability
have been reported [3]. Fusion proteins displayed on
bacterial surface can be subjected to FACS (fluorescence-
activated cell sorting) and ELISA (enzyme-linked immu-
nosorbent assay) to facilitate high throughput screenings
[4]. The strict genotype to phenotype linkage of the auto-
transporter system aids phenotypic selections [5].
Furthermore autotransporters can also be expressed in
other Gram negative bacteria making it highly versatile
[6,7]. Epitopes displayed have been reported to elicit
strong immune stimulation, making it a suitable medium
for potential live vaccine development [8].
Cell surface display with autotransporters has its
drawbacks. Disulphide bond formation within the
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translocation but this has been addressed by inactivating
dsbA, a dithiol oxidase, which assists in disulphide bond
formations in periplasmic proteins [7,9,10]. The success-
ful translocation of the single chain immunoglobulin
fragment with a disulfide bridge to the bacterial surface
[11] suggest that the final dimension of the heterologous
protein is the limiting factor rather than the presence of
the disulfide bridge. OmpT, an outer membrane (OM)
protease, has been shown to cleave exogenous proteins
after translocation, thus it is important to use a host
strain with an ompT deletion [7,9].
The autotransporter protein IcsA (or VirG) is a key viru-
lence factor of Shigella flexneri. It is polarly distributed on
the OM and is essential for mediating Shigella’s intra- and
intercellular motility in the host colonic epithelium
through activation of the host neural Wiskott-Aldrich
syndrome protein (N-WASP) and subsequent actin
nucleation through the Arp2/3 complex [12-16]. The
120 kDa IcsA protein is a typical autotransporter with
three distinct regions; an N-terminal signal sequence
(amino acids (aa) 1-52), a central effector domain or a
domain (aa 53-758) and a C-terminal translocation
domain or b domain (aa 759-1102) [17]. The translocation
of the IcsA polypeptide from the cytoplasm to the peri-
plasm is directed by its unusually long signal sequence via
the Sec pathway [18]. The signal sequence is also crucial
in maintaining the stability of fusion constructs [19]. In
the periplasm, an intramolecular disulphide bridge is
formed in the IcsA a domain [20]. The 80 kDa a domain
is exported to the extracellular milieu when the 37 kDa b
domain inserts itself into the OM [17]. The translocation
unit of NalP (Neisseria meningitides), EspP (E. coli strain
O157:H7) and the trimetric EstA (Pseudomonas aerugi-
nosa) autotransporters are made up of a 12 stranded
C-terminal b-barrel pore with a N-terminal a-helix
inserted into the pore itself [21-23]. The IcsA translocation
unit is likely to adopt a similar confirmation with a pre-
dicted N-terminal a-helix [15]. IcsAa can be cleaved on
the surface by its specific protease IcsP (SopA) between
Arg758-Arg759 [24-26].
In most examples of autotransporter-based display
systems, the native a domain is replaced with the pep-
tide or protein of interest and is expressed as a single
polypeptide with the b domain [3,6,15]. Previously the
FimH lectin domain was fused to a portion of the E. coli
Antigen 43 (Ag43) autotransporter a domain and was
exported to the cell surface by the Ag43 b domain. The
chimeric protein was expressed, its function retained
and was presented on the surface of the Salmonella
enterica host strain [6]. This suggest that the presence
of the a domain, at least a portion of it is not detrimen-
tal to the stability of the chimeric polypeptide.
Recently Saurí et al. suggested that the native a and b
domains of ATs form specific interactions which facili-
tate efficient translocation of the a domain [27]. Repla-
cement of the haemoglobin protease (Hbp) b domain
with the closely related EspP b domain, resulted in the
secretion of the Hbp a domain, albeit with reduced effi-
ciency [27]. Increasing or decreasing the size of the Hbp
b domain by modifying the number of b strands also
affected translocation of the a domain [27]. Further-
more the conserved residues of the a-helix embedded
inside the EspP b domain is not crucial for efficient
translocation but is indispensable for proteolytic release
of the Hbp a domain [28].
In this report, the stability and expression in E. coli
K-12 UT5600 (ΔompT) of TEM-1 b-lactamase (Bla) and
E. coli maltose binding protein (MalE or MBP) fused to
either the full length IcsA protein (IcsA) or to the b
domain alone (IcsAb) was compared to determine the
contribution of the a domain to the stability, expression
and surface localisation of the chimeric proteins. The
outcomes of this study will aid in future cell surface dis-
play design and also in improving our understanding of
the autotransporter export pathway.
Results & discussion
Construction of IcsA and IcsAb fusion proteins
In a previous study, a NotI site was inserted into icsA,a s
part of a 15 nucleotide in-frame insertion at amino acid
87 (icsAi87, TGCGGCCGCAATGGA: amino acid 88-92,
nucleotide 261-270) [29]. icsAi87 will herein be referred
as icsA. icsA was cloned via digestion with EcoRI and SalI
with likewise digested pBAD33 to generate pMLRM1
(Figure 1). In a previous study, IcsAb (amino acid 764-
1102) was fused to maltose binding protein (MalE/MBP)
and alkaline phosphatase to dissect the IcsA export path-
way [15]. The C-terminal b-barrel pore and the
embedded N-terminal a-helix, herein referred as icsAb
(amino acid 764-1102), was amplified from pMLRM1
with a forward primer incorporating a NotI restriction
site and a reverse primer incorporating a SalI restriction
site. icsAb was cloned via digestion with NotIa n dSalI
with likewise digested pBAD33 to generate pMLRM2.
The expression of the icsA and icsAb coding regions in
pMLRM1 and pMLRM2, respectively, is under the con-
trol of the tightly regulated arabinose-inducible araBAD
promoter [30].
IcsA and IcsAb proteins fused to the 29 kDa Bla and 44
kDa MalE were generated to investigate the contribution
of the IcsA passenger domain to the overall stability of
the chimeric proteins (Figure 2). Both Bla and MalE are
relatively globular and have been used in various auto-
transporter studies [15,31]. The bla and malE coding
regions were subcloned from pKMRM1 and pMAL-c2,
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Figure 1 Schematic representation of the construction of pMLRM1 and pMLRM2. icsA was amplified from pKMRM1 and was cloned into
pBAD33, resulting in pMLRM1. icsAb was amplified from pMLRM1 and was cloned into pBAD33, resulting in pMLRM2. The NotI site
(TGCGGCCGC: amino acid 88-91, nucleotide 262-270) of icsA and icsAb serves as the insertion site for bla (TEM-1 beta lactamase) and malE (E. coli
maltose binding protein). pBAD is the arabinose inducible promoter, ss represents the IcsA signal peptide, a represents the IcsA passenger
domain and b represents the IcsA translocator domain. Drawing is not to scale.
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ating a NotI restriction site resulting in pMLRM28
(pMLRM1::bla), pMLRM20 (pMLRM2::bla), pMLRM39
(pMLRM1::malE) and pMLRM37 (pMLRM2::malE). Fig-
ure 1 outlines the construction of these plasmids. The
plasmids were transformed into an ΔompT E. coli K-12
strain, UT5600, to prevent fusion protein cleavage by
OmpT, an OM protease [7,9].
Effects of pMLRM1 and pMLRM2 fusion protein
expression on the growth of E. coli K-12 UT5600
The effects of inducing the pBAD promoter in
pMLRM1::bla and pMLRM2::bla were compared to
pMLRM1 and pBAD33 in the E. coli K-12 UT5600
strain. The growth rates of UT5600 carrying pMLRM1,
pMLRM1::bla and pMLRM2::bla were comparable to
UT5600 carrying pBAD33 (data not shown, Additional
file 1: Figure S1).
Expression of chimeric IcsA and IcsAb fusion proteins
Production of the chimeric IcsA-Bla, IcsAb-Bla, IcsA-MalE
and IcsAb-MalE in UT5600 were examined by SDS-PAGE
and Western immunoblotting after arabinose induction.
At every 30 min, a 1 mL sample was taken and kept on ice
before they were standardised to 1 × 10
8 bacteria/mL with
2× sample buffer. All pMLRM1 chimeric constructs were
immunoblotted with both a-IcsA and also the respective
specific antibodies (a-Bla, a-MBP). All pMLRM2 chimeras
were only blotted with the respective specific antibodies
since our anti-IcsA serum does not recognise the b
domain of IcsA.
IcsA induced from UT5600 (pMLRM4) was immuno-
blotted with a-IcsA as shown in Figure 3A. The amount
of IcsA detected did not appear to be increase over the
2 h time course; the smaller MW bands were probably
IcsA breakdown products.
IcsA-Bla induced from UT5600 (pMLRM28) was
immunoblotted with a-IcsA and a-Bla (Figure 3B and
3C). Increasing amounts of proteins were detected over
the time course of pMLRM28 induction. Small amounts
of degraded proteins were observed after 2 h (Figure 3B
and 3C, lane 5). When IcsAb-Bla induced from UT5600
(pMLRM20) was imunoblotted with a-Bla (Figure 3B),
low levels of IcsAb-Bla was detected without any
increase in protein levels over time. A smaller 60 kDa
IcsAb-Bla was also consistently observed.
IcsA-MalE induced from UT5600 (pMLRM39) was
detected by immunoblotting with a-IcsA and a-MBP
(Figure 3E and 3F). Increasing amounts of the fusion pro-
tein were detected over the time course of pMLRM39
induction. Degraded IcsA-MalE proteins appeared after 1
h induction of pMLRM39 arabinose induction, consistent
with the observed increased amount of protein produc-
tion (Figure 3E and 3F, lanes 3-5). When IcsAb-MalE
induced from UT5600 (pMLRM37) was immunoblotted
with a-MBP (Figure 3G), the 81 kDa IcsAb-MalE was not
detected. Instead two bands of approximately 44 kDa and
60 kDa were observed.
It was expected that the expression of all constructs
subcloned into the pBAD33-based vectors would
increase when the strains were induced with arabinose.
This was observed for IcsA-Bla (Figure 3B and 3C). In
the case of IcsAb-Bla, the expression level of the protein
remained constant over a period of 2 h (Figure 3D). The
consistency of the protein levels induced from the
Figure 2 Summary of IcsA and IcsAb fusion proteins.B l a c k
boxes represent the IcsA signal peptide (ss), light grey boxes
represent the 80 kDa IcsAa (a) and white boxes represent the 37
kDa IcsAb (b). TEM-1 beta lactamase (Bla) and maltose binding
protein (MalE/MBP) are represented by dark grey boxes. Predicted
molecular weights are shown in parentheses.
120 kDa IcsA 
A  30’ 60’ 90’ 120’ 0’ 
1 2 3 4 5 
120 kDa 
85 kDa 
B  0’ 30’ 60’  90’ 120’ 
1 2  3  4  5 
150 kDa IcsA-Bla 
1 2  3  4  5 
C  0’ 30’  60’  90’  120’ 
120 kDa 
60 kDa 
85 kDa 
1 2 3 4 5 
73 kDa IcsAɴ-Bla 
*  60 kDa IcsAɴ-Bla 
D  0’ 30’ 60’  90’ 120’ 
60 kDa 
50 kDa 
1 2  3  4  5 
44 kDa MalE† 
Non-specific binding 
G 0’ 30’ 60’  90’ 120’ 
40 kDa 
190 kDa 
120 kDa 
85 kDa 
60 kDa 
1 2  3  4  5 
E  0’ 30’ 60’  90’ 120’ 
1 2 3  4  5 
F 
164 kDa IcsA-MalE
0’ 30’  60’  90’  120’ 
0’ 30’ 60’  90’ 120’  H 
60 kDa 
50 kDa 
40 kDa  44 kDa MalE† 
Non-specific binding 
1 2  3  4  5 
Figure 3 Analysis of IcsA/IcsAb fusion protein production.
UT5600 strains were grown to mid-log phase and induced with
0.2% (w/v) arabinose. Samples were taken at times indicated.
Approximately 1 × 10
8 bacteria were solubilised, electrophoresed on
a 12% SDS-polyacrylamide gel and subjected to Western
immunoblotting. Immunoblotting of (A) MLRM4 (pMLRM1) with
anti-IcsA; (B) MLRM28 (pMLRM1::bla) with anti-IcsA and (C) anti-Bla;
(D) MLRM20 (pMLRM2::bla) with anti-Bla; (E) MLRM39 (pMLRM1::
malE) with anti-IcsA and (F) anti-MBP; (G) MLRM37 (pMLRM2::malE)
with anti-MBP; (H) UT5600 with anti-MBP. The apparent molecular
sizes of the proteins are indicated. *Protein degradation products
†MalE induced due to chromosomal gene in UT5600
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induced from pMLRM1 (Figure 3A).
Due to the rapid induction of the pBAD promoter, it is
likely that the maximal protein induction has been reached
by 30 min. Consistent with this hypothesis, degraded pro-
teins were observed for both 120 kDa IcsA (Figure 3A,
lanes 1-4) and 150 kDa IcsA-Bla (Figure 3B and 3C, lane
5). The sizes of the degraded proteins were greater than
85 kDa in both cases. Compared to IcsA-Bla, very low
levels of the 73 kDa IcsAb-Bla was expressed (Figure 3D).
The presence of a smaller 60 kDa protein suggests degra-
dation of IcsAb-Bla was rapid and smaller polypeptides
were subsequently not detected by Western immunoblot-
ting. It can be concluded that Bla fused to IcsA resulted in
higher levels of but not necessarily more stable chimeras
compared to fusion to IcsAb.
Over the 2 h induction with arabinose, increasing
amounts of proteins, both full length and degraded (≥ 60
kDa) were observed for IcsA-MalE (Figure 3E and 3F,
lanes 3-5). IcsA-MalE was cleaved either during or after
translocation from the periplasm to the OM. No IcsAb-
MalE was observed by whole cell western immunoblotting
even though a slower induction at 25°C was attempted
(not shown). Increasing amounts of a 44 kDa protein, cor-
responding to MalE was present at all time points after
arabinose induction (Figure 3G). As MalE expression was
induced in UT5600 alone by the presence of arabinose
(Figure 3H), hence the 44 kDa MalE protein was back-
ground MalE expression by UT5600. The lack of IcsAb-
MalE expression cannot be explained at this stage. No
mutations were identified in DNA sequencing, and pre-
vious attempts to detect MalE fusions to the translocation
domain of IcsA and other autotransporters have been suc-
cessful [15,32].
OM localisation
To determine if the fusion chimeras were presented on
the surface of UT5600, two different approaches were
undertaken; cell fractionation and immunofluorescence
(IF) microscopy.
The UT5600 strains (MLRM28 - pMLRM1::bla,
MLRM20 - pMLRM2::bla, MLRM39 - pMLRM1::malE,
MLRM37 - pMLRM2::malE) were subjected to cell frac-
tionation to determine if the IcsA and IcsAb chimeras
were located in the OM.
The 150 kDa band corresponding to IcsA-Bla was
detected in the whole membrane (WM) and OM when
immunoblotted with a-Bla and a-IcsA (Figure 4A and
4B, lanes 2 and 4). IcsAb-Bla was also detected in the
WM and OM (Figure 4A, lanes 6 and 8). A band corre-
sponding to the size of the mature 29 kDa Bla was
observed in the soluble fraction (S) and the inner mem-
brane (IM) of UT5600 strains expressing IcsA-Bla
(MLRM28) and IcsAb-Bla (MLRM20) (Figure 4A, lanes
1, 3, 5 and 7). The association of the Bla protein at the
IM has not been reported previously and is most likely
due to an artefact from fractionation. Degraded proteins
(< 120 kDa) were observed for IcsA-Bla (Figure 4A and
4B, lanes 2 and 4) but not IcsAb-Bla in the WM and
OM fractions (Figure 4A, lanes 6 and 8).
IcsA-MalE (pMLRM1::malE) was detected in both the
WM and OM fractions of UT5600 when immuno-
blotted with a-IcsA and a-MBP (Figure 4C and 4D,
lanes 2 and 4). MalE-related bands (> 70 kDa) were also
observed, similar to immunoblotting results following
induction with arabinose (Figure 3E and 3F).
Surface localisation
IF microscopy was carried out to determine if the chi-
mera IcsA and IcsAb were presented on the surface of
UT5600. The chimeric IcsA autotransporters were
detected with a-IcsA (Figure 5A). As expected the posi-
tive control (pMLRM4 - pBAD33::icsA) was detected on
the cell surface on both the lateral and polar regions of
UT5600. The negative control for a-IcsA was UT5600
(pBAD33) (pMLRM3) and cell surface labelling was not
190 kDa 
120 kDa 
85 kDa 
60 kDa 
A  IcsA-Bla  IcsAɴ-Bla 
IM  WM  S OM 
7  6  3  2  1 4  5  8 
IM  WM  S OM 
73 kDa IcsAɴ-Bla 
150 kDa IcsA-Bla
29 kDa Bla 
50 kDa 
40 kDa 
25 kDa 
150 kDa IcsA-Bla 
B 
WM  S OM  IM 
IcsA-Bla 
3  2  1 4 
190 kDa 
120 kDa 
85 kDa 
D 
WM  S OM  IM 
IcsA-MalE 
3  2  1 4 
190 kDa 
120 kDa 
85 kDa 
164 kDa IcsA-MalE 
C 
WM  S OM  IM 
IcsA-MalE 
3  2  1 4 
164 kDa IcsA-MalE  190 kDa 
120 kDa 
85 kDa 
Figure 4 Detection of IcsA and IcsAb fusion proteins in the OM.
UT5600 strains were grown to mid-log phase, induced with 0.2%
(w/v) arabinose and were fractionated into soluble fraction (S),
whole membrane (WM), inner membrane (IM) and outer membrane
(OM). Equivalent amounts of protein extracts from each fraction
were loaded and analysed by Western immunoblotting.
Immunobloting of fractions from (A) MLRM28 (pMLRM1::bla) and
MLRM20 (pMLRM2::bla) with anti-Bla; (B) MLRM28 (pMLRM1::bla)
with anti-IcsA; (C) MLRM39 (pMLRM1::malE) with anti-MBP and (D)
anti-IcsA. The apparent molecular sizes of the proteins are indicated.
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MalE were labelled with a-IcsA on both the lateral and
polar regions, consistent with the OM localisation
observations from cell fractionation (Figure 4B and 4D).
UT5600 strains expressing Bla chimeras were immunos-
tained with a-Bla to determine if the Bla moiety was
presented on the surface of UT5600 (Figure 5B).
UT5600 strain expressing IcsA (pMLRM4) was not
labelled with a-Bla, as expected. Both Bla chimeras,
IcsA-Bla and IcsAb-Bla were detected on the lateral and
polar regions of UT5600. The staining of UT5600
(pMLRM28 - IcsA-Bla) (35% of bacteria labelled) was
greater than UT5600 (pMLRM20 - IcsAb-Bla) (5% of
bacteria labelled). However compared to a-IcsA staining
(Figure 5A), fewer IcsA-Bla expressing cells were
detected with a-Bla, suggesting that the Bla moiety was
cleaved, either during or after transport from the cyto-
plasm. The low level of IcsAb-Bla detected for UT5600
(pMLRM20 - IcsAb-Bla) was not surprising, given that a
low level IcsAb-Bla was detected by Western immuno-
blotting (Figure 3D).
UT5600 strains expressing MalE chimeras (pMLRM39
- IcsA-MalE and pMLRM37- IcsAb-MalE) were immu-
nostained with a-MBP to determine if MalE was pre-
sented on the bacterial surface (Figure 5C). As expected
the negative control, UT5600 (pMLRM4 - pBAD33::
icsA) was not labelled with a-MBP. IcsA-MalE was
detected on both the lateral and polar regions of
UT5600 (pMLRM39) in all the cells, similar to labelling
with a-IcsA (Figure 5A). None of UT5600 (pMLRM37)
expressing IcsAb-MalE had reacted with a-MBP.
Activity of bla fusion proteins
The activity of the Bla fusion proteins was assessed by
measuring the ampicillin resistance of MLRM28 (IcsA-
Bla) and MLRM20 (IcsAb-Bla). Bacterial cells were
mixed with soft agar and were overlaid on solidified
media. The diameter of the zone of bacterial inhibition
i nt h ep r e s e n c eo f1 5 0μg ampicillin was measured.
Mean values representing three independent experi-
ments and SEM are presented in Figure 6.
The ampicillin resistance of MLRM28 (IcsA-Bla) and
MLRM20 (IcsAb-Bla) were compared to MLRM4 (IcsA)
and KMRM1, the original strain from which bla was
originally amplified from in three different conditions:
LB alone, LB with 0.2% (w/v) glucose and LB with
0.02% (w/v) arabinose. Glucose represses the pBAD pro-
moter, hence the resistance of the Bla constructs when
g r o w no nL Ba g a rs h o u l db es i m i l a rt oL Bw i t h0 . 2 %
(w/v) glucose agar. Higher resistance levels towards
ampicillin was anticipated for bacterial cultures overlaid
on 0.02% (w/v) arabinose plates.
Strain KMRM1 expressing Bla displayed 100% resis-
tance towards ampicillin and was not affected by the
growth media. No observable differences in resistance
were noted for Bla fusion proteins grown on LB and LB
+ 0.2% (w/v) glucose, as expected. MLRM28 (IcsA-Bla)
was more resistant to ampicillin compared to MLRM20
(IcsAb-Bla). This is not surprising given that more IcsA-
Bla was detected via Western immunoblotting compared
to IcsAb-Bla (Figure 3B, C and 3D). Furthermore a third
of UT5600 expressing IcsA-Bla was presented on the
bacterial surface compared to 5% of cells expressing
IcsAb-Bla (Figure 5B). Overall the ability of the UT5600
IcsA pBAD33 IcsAͲBla IcsAͲMalE A
100% 100% 100%
IcsA IcsAͲBla IcsAɴͲBla B
35% 5%
IcsA IcsAͲMalE C
100%
IcsAɴͲMalE
Figure 5 Detection of IcsA and IcsAb fusion proteins on the
surface of UT5600 strains. Immunofluorescence microscopy
showing surface presentation of pBAD33 (empty vector) (MLRM3),
IcsA (MLRM4), IcsA-Bla (MLRM28), IcsAb-Bla (MLRM20), IcsA-MalE
(MLRM39) and IcsAb-MalE (MLRM37) with (A) anti-IcsA; (B) anti-Bla;
(C) anti-MBP. Phase contrast microscopy (upper panels) and
fluorescence microscopy (lower panels) were performed. Specific
proteins were detected with their respective antibodies and were
detected by FITC-labelled anti-rabbit immunoglobulin serum. The
relative percentage of FITC-positive cells are indicated (n = 100)
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presence of ampicillin suggest proper folding of the Bla
moiety and retention of enzymatic activity when fused
to IcsA and IcsAb.
Conclusions
The export pathway of autotransporters is not well
understood but recent evidence suggests that the native
effector domain plays a critical role in facilitating its own
translocation when it traverses through the translocation
domain via interactions with specific residues [27]. A
direct comparison between heterologous proteins fused
to full length autotransporter and heterologous proteins
fused to the translocation domain has previously not
been reported. In this study, protein expression and sur-
face localization of Bla and MalE fused to full length IcsA
and IcsAb alone was compared.
The overall data suggest that fusion of exogenous pro-
teins close to the amino terminal of the IcsA autotran-
sporter passenger domain significantly improves protein
expression and surface presentation when compared to
chimeras fused directly to the IcsA translocation domain.
Differences in protein expression, OM localisation and
surface presentation between chimera proteins of full
length IcsA and IcsAb was to some extent dramatic. For
both Bla and MalE, expression of IcsA fusions was
greater than IcsAb chimeras. However the overall expres-
sion of IcsAb itself could not be assessed, therefore its
contribution to the lack of IcsAb chimera expression can-
not be ruled out. Surface presentation of IcsA chimeras
were also significantly greater compared to IcsAb as
determined by IF microscopy. Degraded MalE and Bla
fusion proteins suggest that some degree of protein
degradation occurred during protein export. Nonetheless
the Bla protein was highly active as UT5600 (MLRM28 -
pMLRM1::bla) and UT5600 (MLRM20 - pMLRM2::bla)
showed resistance towards ampicillin.
Overall, the results here suggest that the autotranspor-
ter display system can be improved dramatically by fus-
ing proteins to the native passenger domain, providing
further evidence for specific interactions between the a
and b domain in protein translocation.
Methods
Bacterial strains, plasmids and growth conditions
The strains and plasmids used in this study are listed in
Table 1. Escherichia coli K-12 strain DH5a was used for
routine cloning and E. coli K-12 strain UT5600 was
used as host cells for the surface display of fusion pro-
teins. All bacterial strains were routinely cultured in
Luria Bertani (LB). Bacteria were grown in media with
antibiotics for 16 h with aeration and then subcultured
1/20 and grown to mid-exponential growth phase by
incubation with aeration for 2 h at 37°C. Bacterial
strains harbouring pBAD33 and derivatives were culti-
vated in LB broth with 0.2% (w/v) glucose. Where
appropriate, media were supplemented with ampicillin
(100 μg/mL) and chloramphenicol (25 μg/mL).
Plasmid construction and DNA methods
In a previous study, a NotI site was inserted into icsA,a s
part of a 15 nucleotide in-frame insertion at aa 87 [icsA,
TGCGGCCGCAATGGA: amino acid 88-92, nucleotide
261-270] [29]. The icsA gene was amplified by PCR from
pKMRM1 with primers 2156_KpnI (5’-GCCGGTAC-
CAACGGAATCTTTTCAGGGG) and REPL.BIO-
pBAD30_Sal (5’-CACGCCCTGTCGACTTATTATCA-
GAAGG) containing KpnIa n dSalI sites, respectively.
The resulting PCR product was digested with KpnIa n d
SalI, and ligated into the KpnIa n dSalIs i t e so ft h e
pBAD33 plasmid to produce pMLRM1 (Figure 1).
The icsAb region of icsA was amplified by PCR from
pMLRM1 with primers IcsA_764_NotI (5’-CTAGCGG
CCGCCTTGTATCTTCAC) and REPL.BIO-pBAD30_Sal
containing NotI and SalI sites, respectively. The PCR pro-
duct was digested with NotI and SalI and ligated between
the NotIa n dSalI sites of the pMLRM1 plasmid to pro-
duce pMLRM2. The bla gene was amplified by PCR from
Figure 6 Ampicillin susceptibility of UT5600 strains expressing
IcsA and IcsAb fusion proteins are resistant to 150 μg ampicillin.
Bacterial strains expressing Bla (KMRM1), IcsA (MLRM4), IcsA-Bla
(MLRM28) and IcsAb-Bla (MLRM20) were added to 5 mL soft agar and
were overlaid onto three different solidified media: LB alone, LB + 0.2%
glucose or LB + 0.2% arabinose. 150 μg ampicillin was spotted onto
sterile Whatman filters, and the agar plate was incubated at 37°C for 16
h. The diameter of the zone of inhibition was measured in millimetre
(mm). KMRM1 is resistant to ampicillin. Data are represented as mean
± SEM of three independent experiments. *p < 0.05
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tI_f (5’-CTGGCGGCCGCCACCCAGAAACGC) and
Bla_NotI_rev3 (5’-GTCGCGGCCGCCCCAATGCT-
TAATCAGTGAG) containing NotI sites. The resulting
PCR product was digested with NotI and ligated into the
NotI site of the pMLRM1 and pMLRM2 plasmids to pro-
duce pMLRM28 and pMLRM20, respectively. The malE
gene was amplified by PCR from a plasmid preparation of
pMAL-c2 with primers MalE_NotI_f (5’-G A C GCG
GCCGCAAAATCGAAGAAGGTA) and MalE_NotI_rev5
(5’-CGAGCGGCCGCCAGTCTGCGCGT CTTTC) con-
taining NotI sites. The resulting PCR product was digested
with NotI and ligated into the NotI site of the pMLRM1
and pMLRM2 plasmids to produce pMLRM39 and
pMLRM37, respectively. DNA sequencing was used to
confirm the integrity of the inserts within the constructed
plasmids. Isolation of plasmid DNA was carried out with
the QIAprep Miniprep kit (Qiagen). Restriction endonu-
cleases were used according to the manufacturer’s specifi-
cations (NEB). General cloning techniques, PCR and DNA
sequencing were performed as described previously [29].
Antibodies and antisera
Affinity-purified rabbit polyclonal anti-IcsA antiserum was
as described previously [34]. Rabbit a-Bla polyclonal anti-
body was from Chemicon, and rabbit a-MBP antiserum
was from NEB. Anti-IcsA was used at 1:1000, and anti-Bla
and anti-MBP were used at 1:10,000.
Measuring growth rate
Ten milliliters 18 h bacterial culture were subcultured
(1/20) into LB + 0.2% (w/v) glucose and were grown for
1 h, washed in 2 × 20 mL pre-warmed fresh LB before
induction with 0.2% (w/v) arabinose in a side arm flask
in an orbital (200 rpm) water bath at 37°C. A spectro-
photometer (Spectronic 20 D+, Milton Roy) was used to
take absorbance readings at 600 nm every 30 min until
the ABS600 reading reached 1.999. The experiment was
repeated twice.
SDS-PAGE and western immunoblotting
Ten milliliters bacterial cultures were subcultured (1/20)
for 2 h, 37°C in LB + 0.2% (w/v) glucose, washed once
in 20 mL fresh LB before induction with 0.2% (w/v) ara-
binose for 2 h at 37°C. 1 mL culture was centrifuged
(13,000 rpm, 1 min, Eppendorf 5415R) and was standar-
dised to 1 × 10
8 bacteria/mL with 2× sample buffer
(0.125 M Tris-HCl, pH 6.8, 4% [w/v] SDS, 20% [v/v] gly-
cerol, 10% [v/v] b-mercaptoethanol, 0.04% [w/v] Bromo-
phenol blue). SDS-PAGE and Western immunoblotting
were carried out as described previously [29]. Molecular
weight markers used were BenchMark™ Pre-Stained
Protein Ladder (Invitrogen).
Cell fractionation
One hundred milliliters bacterial cultures were subcul-
tured (1/20) for 2 h, 37°C in LB + 0.2% (w/v) glucose and
were pelleted by centrifugation (8,000 rpm, 15 min, 4°C,
Beckman Model J2-21 M). Cultures were washed in 2 ×
20 mL fresh LB and induced with 0.2% (w/v) arabinose
for 2 h at 37°C. Bacteria were pelleted by centrifugation
(8,000 rpm, 15 min, 4°C, Beckman Model J2-21M), pellet
washed with 3 mL 50 mM Tris-HCl (pH 8.0) and resus-
pended in 10 mL HEPES/1 mM MgCl2.C u l t u r e sw e r e
Table 1 Bacterial strains and plasmids
Strain or plasmid’ Relevant characteristics Reference or source
E. coli K-12
DH5a F
- 80lacZΔM15 Δ(lacZYA-argF)U169 recA1 endA1 hsdR17(rk
-,m k
+) phoAsupE44 thi-1 gyrA96 relA1 l- Gibco-BRL
KMRM1 DH5a [pKMRM1]; Amp
R [29]
MLRM3 UT5600 [pBAD33]; Cm
R This study
MLRM4 UT5600 [pMLRM1]; Cm
R This study
MLRM20 UT5600 [pMLRM2::bla (NotI-NotI)], Cm
R This study
MLRM28 UT5600 [pMLRM1::bla (NotI-NotI)], Cm
R This study
MLRM37 UT5600 [pMLRM2::malE (NotI-NotI)], Cm
R This study
MLRM39 UT5600 [pMLRM1::malE (NotI-NotI)], Cm
R This study
RMA3045 E1315 [pMAL-c2], Amp
R Laboratory collection
UT5600 F
- ara-14 leuB6 secA6 lacY1 proC14 tsx-67 Δ(ompT-fepC)266 entA403 trpE38 rfbD1 rpsL109 xyl-5 mtl-1 thi-1 Laboratory collection
Plasmids
pBAD33 pBAD expression; pACYC184 ori; Cm
R [30]
pIcsA icsA (EcoRI-SalI) gene cloned into pBR322; medium copy no.; ColE1 ori; Amp
R [33]
pKMRM1 pIcsA::5aa insertion at amino acid position 87 (icsAi87 or icsA)( bla); Amp
R [29]
pMLRM1 icsA (KpnI-SalI) gene cloned into pBAD33 (pBAD33::icsA), Cm
R This study
pMLRM2 icsAß (amino acid 764-1102) (NotI-SalI) cloned into pMLRM1 (pBAD33::icsAb); Cm
R This study
pMAL-c2 pMAL-c2 (malE); Amp
R New England Biolabs
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Page 8 of 10passaged through a French press and cell debris was pel-
leted by centrifugation (4,500 rpm, 15 min, RT, Sigma
3K15). The supernatant was pelleted by centrifugation
(35,000 rpm, 1 h, 4°C, Beckman Coulter Optima™ L-100
Ultracentrifuge). A sample of the pellet (WM - whole
membrane) was kept and resuspended in 100 μL 2× sam-
ple buffer. 10 μL of the supernatant (S/N) (soluble frac-
tion) was mixed with 100 μL1 ×s a m p l eb u f f e r .T h eW M
pellet was resuspended in 2.5 mL Triton/MgCl2 and was
incubated at RT, shaking for 30 min. The mixture was
pelleted by centrifugation (35,000 rpm, 1 h, 4°C, Beck-
man Coulter Optima™ L-100 Ultracentrifuge). A sample
of the pellet (outer membrane) was kept and resuspended
in 100 μL 2× sample buffer. 10 μL of the S/N (inner
membrane) was mixed with 100 μL1 ×s a m p l eb u f f e r .
Proteins were subjected to SDS-PAGE and detected via
Western immunoblotting with specific antibodies.
Indirect immunofluorescence (IF) of whole bacteria
Ten milliliters bacterial cultures were subcultured (1/20)
for 2 h, 37°C in LB + 0.2% (w/v) glucose and were pel-
leted by centrifugation (13,000 rpm, 1 min, Eppendorf,
5415 R). Cultures were resuspended in 20 mL fresh LB
and were pelleted by centrifugation (13,000 rpm, 1 min).
Bacterial cultures were resuspended in 10 mL LB + 0.2%
(w/v) arabinose and were induced for 2 h at 37°C. 500 μL
of bacteria were pelleted by centrifugation (13,200 rpm,
1 min) and the supernatant discarded. Bacteria were
fixed in 500 μL formalin (3.7% paraformaldehyde in
0.85% saline) for 30 min at room temperature. Fixed bac-
teria were pelleted by centrifugation (13,000 rpm, 1 min)
and were resuspended in 500 μL phosphate-buffered sal-
ine (PBS). Fixed bacteria were pelleted by centrifugation
(13,000 rpm, 1 min) and were resuspended in 100 μL
PBS. Sterile cover-slips were placed in a 24-well tray and
were incubated with filter sterilised poly-L-lysine (0.01%
( w / v )i nP B S )f o r1m i na n dw a sa s p i r a t e d .T h ec o v e r -
slips were washed with PBS before 4 μLo ff o r m a l i nf i x e d
bacteria were centrifuged onto the cover-slips (2,500
rpm, 5 min, Heraeus Labofuge 400 R). The bacteria were
washed twice in PBS and were incubated with the specific
primary antibody diluted 1:100 with 10% foetal calf
serum (FCS). Bacteria were washed thrice in PBS and
incubated with Alexa 488-conjugated donkey anti-rabbit
secondary antibody (Molecular Probes) in PBS with 10%
FCS. Cover slips were washed thrice in PBS were
mounted on glass slides with Mowiol 4-88 (Calbiochem)
containing 1 mg/mL p-phenylenediamine (Sigma) and
examined with an Olympus IX-70 microscope with
phase-contrast optics using a 100× oil immersion objec-
tive and a 1.5× enlarger as required. Fluorescence and
phase contrast images were false colour merged using the
Metamorph software program (version 6.3r7; Molecular
Devices).
Ampicillin susceptibility testing
Ten milliliters bacterial cultures were subcultured (1/20)
for 2 h, 37°C in LB + 0.2% (w/v) glucose and were pel-
leted by centrifugation (13,000 rpm, 1 min, Eppendorf,
5415 R). Cultures were resuspended in 20 mL fresh LB
and were pelleted by centrifugation (13,000 rpm, 1 min).
Bacterial cultures were resuspended in 10 mL LB + 0.2%
(w/v) arabinose and were induced for 2 h at 37°C. 100 μL
of bacteria (5 × 10
7 cells total) were added to the 5 mL
soft agar (1:1 LB agar to LB broth, 56°C), swirled before it
was overlayed onto pre-warmed LB agar (42°C) and
allowed to set. 6 mm sterile Whatman filters were placed
onto the agar and were soaked with a 150 μg ampicillin
solution. The filter was allowed to dry before incubation
at 37°C for 16 h. The diameter of the zone of inhibition
was measured. The experiment was repeated twice.
Statistical analysis
Statistical analysis was carried out using GraphPad Prism
5. Results are expressed as means ± SEM of data obtained
in independent experiments. Statistical differences
between groups were determined with two-tailed unpaired
t-test. Statistical significance was set at p < 0.05.
Additional material
Additional file 1: Figure S1. Expression of IcsA-Bla and IcsAb-Bla does
not affect UT5600 growth. The growth of UT5600 strains carrying
pMLRM1::bla (MLRM28) and pMLRM2::bla (MLRM20) were comparable to
pBAD33 (MLRM3) and pMLRM1 (MLRM4). An absorbance reading at 600
nm for each culture was taken every 30 min until the reading reached
1.999. Data are represented as mean ± SEM of three independent
experiments.
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